Stereotactic ablative Radiotherapy in Patients with oligometastatic Prostate Cancer

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE UROLOGIE | 2021年 / 52卷 / 01期
关键词：
D O I：
10.1055/a-1170-9469
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Das metastasierte Prostatakarzinom ist nicht heilbar. Stellt die stereotaktische ablative Radiotherapie (SABR) fur Patienten mit einer Oligometastasierung eine effektive Alternative zur nebenwirkungsreichen Androgenentzugstherapie dar? Dieser Frage ging ein Team von US-Wissenschaftlern im Rahmen der ORIOLE-Studie nach.
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] TWO SEQUENTIAL PILOT STUDIES: STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC BREAST CANCER (BOSTON) AND STEREOTACTIC ABLATIVE RADIOTHERAPY plus PEMBROLIZUMAB FOR OLIGOMETASTATIC BREAST CANCER (BOSTON II)
    David, Steven
    Siva, Shankar
    Bressel, Mathias
    Savas, Peter
    Foroudi, Farshad
    Loi, Sherene
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 167 - 167
  • [22] Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa, Rohann J. M.
    Palma, David A.
    [J]. LANCET ONCOLOGY, 2021, 22 (01): : 6 - 8
  • [23] Tumor Control Probability Modeling and Systematic Review of Oligometastatic Prostate Cancer Treated with Stereotactic Ablative Radiotherapy
    Koerner, S. A.
    Wang, H.
    Olson, A. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E225 - E226
  • [24] Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)
    Cheung, P.
    Morton, G.
    Chung, H. T.
    Vesprini, D.
    Chu, W.
    Liu, S. K.
    Tseng, C. L.
    Sahgal, A.
    Soliman, H.
    Myrehaug, S. D.
    Szumacher, E.
    Chung, P.
    Helou, J.
    Emmenegger, U.
    Erler, D.
    Mamedov, A.
    Chan, S.
    Zhang, L.
    Loblaw, D. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E269 - E270
  • [25] Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.
    Tran, Phuoc T.
    Moyer, C. Leigh
    Phillips, Ryan
    Radwan, Noura
    Ross, Ashley
    Reyes, Diane K.
    Wright, Jean
    Antonarakis, Emmanuel S.
    Song, Daniel Y.
    Deville, Curtiland
    Walsh, Patrick C.
    DeWeese, Theodore L.
    Carducci, Michael Anthony
    Schaeffer, Edward M.
    Pienta, Kenneth J.
    Eisenberger, Mario A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Role of stereotactic radiotherapy in the management of patients with oligometastatic prostate cancer Stereotactic body radiation therapy for oligomastatic prostate cancer
    Bibault, Jean-Emmanuel
    [J]. BULLETIN DU CANCER, 2018, 105 (01) : 120 - 125
  • [27] Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
    Donovan, Elysia K.
    Lo, Simon S.
    Beriwal, Sushil
    Chen, Hanbo
    Cheung, Patrick
    Keller, Andrew
    Nwachukwu, Chika
    Mantz, Constantine
    Pond, Gregory R.
    Schnarr, Kara
    Swaminath, Anand
    Albuquerque, Kevin
    Leung, Eric
    [J]. JAMA ONCOLOGY, 2024, 10 (07) : 941 - 948
  • [28] Choline PET/CT and Stereotactic Body Radiotherapy in oligometastatic prostate cancer patients
    Pasqualetti, F.
    Panichi, M.
    Sainato, A.
    Matteucci, F.
    Derosa, L.
    Cocuzza, P.
    Coraggio, G.
    Ferrazza, P.
    Montrone, S.
    Cantarella, M.
    Delishaj, D.
    Cristaudo, A.
    Fabrini, M.
    Greco, C.
    Erba, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S353 - S354
  • [29] Stereotactic ablative radiotherapy for oligometastatic disease: why and how?
    Widder, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S246 - S247
  • [30] Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease
    Broomfield, J. A.
    Greenspoon, J. N.
    Swaminath, A.
    [J]. CURRENT ONCOLOGY, 2014, 21 (03) : 115 - 117
12345